IDERA PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements

41 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of the Aceragen, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
IDERA PHARMACEUTICALS, INC.
Biotechnology
2023
Project Agreement No. 01, by and between Advanced Technology International and Arrevus, Inc., dated August 24, 2021
IDERA PHARMACEUTICALS, INC.
Biotechnology
2022
Base Agreement, by and between Advanced Technology International and Arrevus, Inc., dated May 28, 2021
IDERA PHARMACEUTICALS, INC.
Biotechnology
2022
Letter Agreement by and among Dan Salain and Aceragen, Inc., dated February 25, 2021
IDERA PHARMACEUTICALS, INC.
Biotechnology
NC
2022
Letter Agreement by and among John Taylor and Aceragen, Inc., dated February 25, 2021
IDERA PHARMACEUTICALS, INC.
Biotechnology
NC
2022
Description of the Idera Pharmaceuticals, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
IDERA PHARMACEUTICALS, INC.
Biotechnology
2021
Description of the Idera Pharmaceuticals, Inc. Securities Registered Under Section 12 of the Securities Exchange Act of 1934
IDERA PHARMACEUTICALS, INC.
Biotechnology
2020
Scientific Advisor Agreement effective June 1, 2017 by and between Idera Pharmaceuticals, Inc. and Sudhir Agrawal
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2018
167 Sidney Street Renewal LOI Idera Pharmaceuticals September 20, 2016
IDERA PHARMACEUTICALS, INC.
Biotechnology
2017
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions
IDERA PHARMACEUTICALS, INC.
Biotechnology
NY
2017
EXHIBIT A Definitions
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2016
EXHIBIT A Definitions
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2015
EXHIBIT A Definitions
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2015
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
IDERA PHARMACEUTICALS, INC.
Biotechnology
IL
2014
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions.
IDERA PHARMACEUTICALS, INC.
Biotechnology
2014
RESTATED CERTIFICATE OFINCORPORATION OF HYBRIDON,INC.
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2014
AGREEMENT
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2013
AGREEMENT
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2013
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Asterisks denote omissions.
IDERA PHARMACEUTICALS, INC.
Biotechnology
2012
IDERA PHARMACEUTICALS, INC.
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2011
AMENDMENT NO. 4 TO RIGHTS AGREEMENT
IDERA PHARMACEUTICALS, INC.
Biotechnology
2011
EX-101 INSTANCE DOCUMENT
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2011
EX-101 INSTANCE DOCUMENT
IDERA PHARMACEUTICALS, INC.
Biotechnology
2011
EX-101 INSTANCE DOCUMENT
IDERA PHARMACEUTICALS, INC.
Biotechnology
2011
Idera Pharmaceuticals, Inc.
IDERA PHARMACEUTICALS, INC.
Biotechnology
2011
FINANCIAL STATEMENTS
IDERA PHARMACEUTICALS, INC.
Biotechnology
NY
2010
FINANCIAL STATEMENTS
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2010
Rodman & Renshaw, LLC 1251 Avenue of the Americas, 20th Floor, New York, NY 10020 Tel: 212 ###-###-#### Fax: 212 ###-###-#### www.rodm.com Member: FINRA, SIPC
IDERA PHARMACEUTICALS, INC.
Biotechnology
NY
2010
Drug candidate(s)
IDERA PHARMACEUTICALS, INC.
Biotechnology
2010
EX-10.1 Offer letter, dated November 27, 2006, as amended
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2009
IDERA PHARMACEUTICALS, INC.
IDERA PHARMACEUTICALS, INC.
Biotechnology
2008
IDERA PHARMACEUTICALS, INC.
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2008
EX-10.1 Letter Agreement dated May 17, 2007, Robert G. Andersen
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2007
EX-4.1 Amendment No. 3 to Rights Agreement, dated as of January 16, 2007
IDERA PHARMACEUTICALS, INC.
Biotechnology
2007
EX-10.5 ENGAGEMENT LETTER
IDERA PHARMACEUTICALS, INC.
Biotechnology
2006
EX-4.1 AMENDMENT NO. 2 TO RIGHTS AGREEMENT
IDERA PHARMACEUTICALS, INC.
Biotechnology
2006
EX-10.7 Noteholders Agreement
IDERA PHARMACEUTICALS, INC.
Biotechnology
MA
2005
EX-10.6 Engagement Letter
IDERA PHARMACEUTICALS, INC.
Biotechnology
2005
EX-10.3 FORM OF WARRANTS ISSUED ON AUGUST 27, 2004
IDERA PHARMACEUTICALS, INC.
Biotechnology
DE
2004
EX-10.1 ENGAGEMENT LETTER DATED AUGUST 27, 2004
IDERA PHARMACEUTICALS, INC.
Biotechnology
2004